---

October 01, 2025

Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform

Adaptive “digital brain” designed to cut risk, cost and timelines in the $70-billion clinical-trials market1 Toronto, Ontario–(Newsfile Corp. – October 1, 2025) – Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) (“Predictmedix” or…

Read full release →

October 01, 2025

Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform

Adaptive “digital brain” designed to cut risk, cost and timelines in the $70-billion clinical-trials market1 Toronto, Ontario–(Newsfile Corp. – October 1, 2025) – Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) (“Predictmedix” or…

Read full release →

July 02, 2025

Predictmedix AI Expands into Mobile Diagnostics with New AI-Driven Diabetes Screening Platform

TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP), a leader in artificial intelligence-driven health screening solutions, is expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive…

Read full release →

May 20, 2025

Predictmedix AI and Pacific Mechatronics Announce Strategic Commercial Alliance to Rapidly Scale AI Health Screening Across Asia-Pacific Defence Sector

TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leader in AI-powered health and safety technology, is proud to announce a high-impact strategic alliance with Pacific Mechatronics Pvt. Ltd.,…

Read full release →

May 08, 2025

Predictmedix AI to Headline Exclusive European Investor Roadshow Across Budapest, Zagreb, and Belgrade

TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-driven health and safety solutions, is proud to announce its participation as one of four profiled companies…

Read full release →